
Validea's guru fundamental report assigns Microsoft (MSFT) an 86% rating under its Warren Buffett-inspired 'Patient Investor' model, indicating strong alignment with criteria for long-term, predictable profitability and low debt. The large-cap growth stock passed most key fundamental tests, including earnings predictability, free cash flow, and return on equity, suggesting it is viewed as a fundamentally sound long-term holding despite failing on initial rate of return.
Microsoft (MSFT) scores a strong 86% on Validea's 'Patient Investor' model, which is based on Warren Buffett's investment principles, indicating a strong alignment with criteria focused on long-term, predictable profitability and low debt. The company passed critical fundamental tests including earnings predictability, return on equity, return on total capital, free cash flow, and share repurchases, underscoring its operational strength and effective capital management. However, a key point of concern is that the stock failed the 'Initial Rate of Return' criterion, suggesting that its current valuation may be too high to provide a compelling entry point for new capital, despite still passing on overall 'Expected Return' for the long term. This presents a classic dilemma of a high-quality company trading at a potentially full price.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment